The signal in the noise—
better investing with The Idea Farm.
Access to over $100,000 worth of investing research, the kind usually read by only the world’s largest institutions, funds, and money managers.
Carlyle
Alternative Assets
|
Feb 2026
Carlyle summarizes the current state of the private markets, highlighting strong deal activity in 2025 and resilient credit markets.
Alternative Assets
February 2026
Carlyle summarizes the current state of the private markets, highlighting strong deal activity in 2025 and resilient credit markets.
Carlyle
The Latest
Goldman Sachs
Elsie Peng
Global Macroeconomics
|
Feb 2026
GMO
Jeremy Grantham, Edward Chancellor
Markets
|
Feb 2026
CFA Institute
Paul McCaffrey
Markets
|
Feb 2026
Join our newsletter to have all of this content
+ Exclusive Newsletter Bonus Content
delivered to your inbox every week
Curated Podcasts
China
Ep.52
Geopolitics
Ep.35
Global Macroeconomics
Ep.45
Global Macroeconomics
Ep.39
Alternative Assets
Ep.60
Editor’s Picks
Verdad
Daniel Rasmussen
Markets
|
Jan 2026
Dan Rasmussen and the Verdad team cover the strangeness of the biotech sector, the recent tribulations that have led to massive underperformance of the broader market, the important role played by specialist biotech funds, the factors that drive performance, how to manage risk, and, ultimately, a strategy for how to invest quantitatively in the biotech sector.
Markets
January 2026
Dan Rasmussen and the Verdad team cover the strangeness of the biotech sector, the recent tribulations that have led to massive underperformance of the broader market, the important role played by specialist biotech funds, the factors that drive performance, how to manage risk, and, ultimately, a strategy for how to invest quantitatively in the biotech sector.
Verdad
Daniel Rasmussen
Markets
Feb 2026
CFA Institute
Paul McCaffrey